+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer

  • Book

  • January 2019
  • Elsevier Science and Technology
  • ID: 4612891

Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Introduction: An Overview of the anatomy and physiology of the lung 2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug Resistance 3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancer 4. Polymeric nanoparticles based drug delivery for lung cancer 5. Solid lipid nanoparticles based drug delivery for lung cancer 6. Liposomes and niosomes based drug delivery for lung cancer 7. Dendrimers based drug delivery for lung cancer 8. Micelles based drug delivery for lung cancer 9. Nanoemulsions based drug delivery for lung cancer 10. Nanomedicine-based inhalation treatments for lung cancer 11. Towards development of novel diagnostic nano-imaging platform for lung cancer 12. Hydrogel based drug delivery for lung cancer 13. Quantum dots based drug delivery for lung cancer

Authors

Prashant Kesharwani Prashant Kesharwani, Assistant Professor, School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India. Dr. Prashant Kesharwani is Assistant Professor of Pharmaceutics at the School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India. He has more than 250 international publications in well reputed journals and 13 international books (Elsevier). He is a recipient of several internationally acclaimed awards viz 'Ramanujan Fellowship, DST, India-2017', 'Excellence Research Award 2014', 'Young Innovator Award (Gold medal) 2012', 'International Travel Award/Grant from DST (New Delhi) and INSA (CCSTDS, Chennai) 2012'. He has received an ICMR Senior Research Fellowship (PhD) and AICTE Junior Research Fellowship (M. Pharm.). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of wider community.